Skip to main content

Study IDs Downstream Procedure, Complication Rates After Lung Cancer Screening

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 2, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 2, 2024 -- For individuals undergoing low-dose computed tomography (LDCT) scans for lung cancer screening (LCS), the rates of downstream procedures and complications are higher than observed in the National Lung Screening Trial (NLST), according to a study published online Jan. 2 in the Annals of Internal Medicine.

Katharine A. Rendle, Ph.D., M.P.H., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study to identify rates of downstream procedures and complications associated with LCS in five U.S. health care systems. Data were included for 9,266 patients who completed a baseline LDCT scan for LCS between 2014 and 2018.

The researchers found that 15.9 percent of the patients had a baseline LDCT scan showing abnormalities, and of these patients, 9.5 percent were diagnosed with lung cancer within 12 months (positive predictive value, 9.5 percent; negative predictive value, 99.8 percent; sensitivity, 92.7 percent; specificity, 84.4 percent). In screened patients, absolute rates of downstream imaging and invasive procedures were 31.9 and 2.8 percent, respectively. Complication rates were substantially higher for those undergoing invasive procedures after abnormal findings than those in the NLST (30.6 versus 17.7 percent for any complication; 20.6 versus 9.4 percent for major complications).

"We observed higher rates of both invasive procedures and complications than those observed in NLST, highlighting the need for practice-based strategies to assess variations in the quality of care and to prioritize LCS among those patients most likely to receive a net benefit from screening in relation to potential complications and other harms," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

Read this next

Mortality in Rheumatic Heart Disease Is High

FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...

Higher County-Level Prostate Cancer Screening Tied to Better Outcomes

FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...

Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer

FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.